Monday, April 30, 2007

Where are we with race-based medicine?


...In 2005, a heart failure drug called BiDil was released as the first therapy for African-Americans only.

…But for years, physicians have known that African-Americans, Hispanics, and Native Americans are more susceptible to diabetes and some other ailments.

…Something in their unique racial makeup also makes them respond differently to some meds. One size does not fit all.

…In other words, race is connected to clinical care.

…Some examples: Asthma patients of Puerto Rican heritage may not respond as well to Albuterol.

…African-Americans also may be more prone to lung cancer as a result of smoking than whites, Japanese-Americans, and Hispanics.

…White and African-American girls process salt differently from each other, with black girls eating more salt, but also retaining more calcium, making them less likely to get osteoporosis.

…In 2005, doctors were urged to give Asian-Americans less Crestor to lower cholesterol. Asian-Americans were getting more side effects.

…Whites benefit more from ACE inhibitors than African-Americans.

…Ruling race in or out is good medicine, one doctor remarked.

…Do you think we have the inside track on this and it’s looked at enough? HA is doubtful..

No comments: